Worland P J, Bronzert D, Dickson R B, Lippman M E, Hampton L, Thorgeirsson S S, Wirth P J
Medical Branch, National Cancer Institute, Bethesda, Maryland 20892.
Cancer Res. 1989 Jan 1;49(1):51-7.
The polypeptide patterns of MCF-7 human breast cancer cells (MCF-7gpt) and a stably v-H-ras-transfected subclone (MCF-7ras) have been analyzed following estradiol treatment. Since both estradiol and v-H-ras transfection increase tumorigenicity of MCF-7 cells, this study was designed to ascertain if specific changes in polypeptides were common in both treatments. Separation of cellular and secreted polypeptides was accomplished by 2-dimensional polyacrylamide gel electrophoresis, and the consequent patterns were analyzed with computer assistance. Estradiol treatment of the MCF-7gpt cells reduced the number of differences found in the polypeptide patterns between MCF-7gpt and MCF-7ras. Twelve cellular polypeptides were consistently modulated by either estradiol or v-H-ras, with four polypeptides clearly affected in the same way by both treatments. Polypeptides Gchc-0845 (Mr 54,000, pI 6.9) and Gchc-0902 (Mr 52,000, pI 6.3) were suppressed by estradiol and v-H-ras, while Gchc-1240 (Mr 34,000, pI 4.4) and Gchc-1396 (Mr 23,000, pI 5.3) were induced by estradiol and v-H-ras. Sixteen secreted polypeptides were altered by at least 2-fold subsequent to estradiol treatment or v-H-ras transfection. Transfection with v-H-ras had a greater effect than estradiol, stimulating the secretion of eight polypeptides and suppressing the secretion of seven polypeptides compared to estradiol which increased secretion of five polypeptides and decreased secretion of an additional three polypeptides, respectively. Synergistic effects by estradiol and v-H-ras were noted for three polypeptides. The secretion of Gcls-175 (Mr 50,000, pI 5.7) and Gcls-320 (Mr less than 14,000, pI 3.6, p-S2) was increased, while the secretion of Gcls-112 (Mr 76,000, pI 6.9) was decreased. Opposing effects of estradiol and v-H-ras were seen for seven polypeptides including the Mr 48,000 derivative of the Mr 52,000 protein (cathepsin D). These studies support the possibility that an extremely few, but specific polypeptides are regulated in association with quite diverse tumorigenic stimuli in MCF-7 human breast cancer cells.
在雌二醇处理后,对MCF - 7人乳腺癌细胞(MCF - 7gpt)和稳定转染v - H - ras的亚克隆(MCF - 7ras)的多肽模式进行了分析。由于雌二醇和v - H - ras转染均增加了MCF - 7细胞的致瘤性,本研究旨在确定两种处理中多肽的特定变化是否常见。通过二维聚丙烯酰胺凝胶电泳实现细胞内和分泌多肽的分离,并借助计算机分析所得模式。对MCF - 7gpt细胞进行雌二醇处理后,减少了MCF - 7gpt和MCF - 7ras之间多肽模式中发现的差异数量。有12种细胞多肽受到雌二醇或v - H - ras的持续调节,其中4种多肽受到两种处理的影响方式相同。多肽Gchc - 0845(分子量54,000,等电点6.9)和Gchc - 0902(分子量52,000,等电点6.3)受到雌二醇和v - H - ras的抑制,而Gchc - 1240(分子量34,000,等电点4.4)和Gchc - 1396(分子量23,000,等电点5.3)受到雌二醇和v - H - ras的诱导。16种分泌多肽在雌二醇处理或v - H - ras转染后至少有2倍的变化。与v - H - ras转染相比,雌二醇的影响较小,v - H - ras刺激了8种多肽的分泌并抑制了7种多肽的分泌,而雌二醇分别增加了5种多肽的分泌并减少了另外3种多肽的分泌。观察到雌二醇和v - H - ras对3种多肽有协同作用。Gcls - 175(分子量50,000,等电点5.7)和Gcls - 320(分子量小于14,000,等电点3.6,p - S2)的分泌增加,而Gcls - 112(分子量76,000,等电点6.9)的分泌减少。对于7种多肽,包括分子量52,000蛋白质(组织蛋白酶D)的分子量48,000衍生物,观察到雌二醇和v - H - ras的相反作用。这些研究支持了这样一种可能性,即在MCF - 7人乳腺癌细胞中,极少数但特定的多肽与多种致瘤刺激相关联而受到调节。